These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17661628)

  • 1. The 15th International Pathogenic Neisseria Conference.
    Tapsall J
    Future Microbiol; 2006 Dec; 1(4):363-4. PubMed ID: 17661628
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae.
    Stefanelli P
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):237-44. PubMed ID: 21342071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired macrolide resistance genes in pathogenic Neisseria spp. isolated between 1940 and 1987.
    Cousin S; Whittington WL; Roberts MC
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3877-80. PubMed ID: 14638497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serogroup A Neisseria meningitidis with reduced susceptibility to ciprofloxacin.
    Strahilevitz J; Adler A; Smollan G; Temper V; Keller N; Block C
    Emerg Infect Dis; 2008 Oct; 14(10):1667-9. PubMed ID: 18826845
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase variation of DNA methyltransferases and the regulation of virulence and immune evasion in the pathogenic Neisseria.
    Seib KL; Jen FE; Scott AL; Tan A; Jennings MP
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neisseria: recent advances and future challenges.
    Criss AK; Tang C
    Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28957453
    [No Abstract]   [Full Text] [Related]  

  • 7. International Forum on Gonococcal Infections and Resistance.
    De Ambrogi M
    Lancet Infect Dis; 2017 Nov; 17(11):1127. PubMed ID: 29115267
    [No Abstract]   [Full Text] [Related]  

  • 8. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis Sequence Type 7926: the first case in Italy, likely imported.
    Vacca P; Vocale C; Fazio C; Ambrosio L; Luzi K; Neri A; Palmieri A; Stefanelli P
    J Glob Antimicrob Resist; 2019 Sep; 18():177-178. PubMed ID: 31325619
    [No Abstract]   [Full Text] [Related]  

  • 9. Neisseria genomics: current status and future perspectives.
    Harrison OB; Schoen C; Retchless AC; Wang X; Jolley KA; Bray JE; Maiden MCJ
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28591853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis).
    Jones RN; Sader HS; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):139-41. PubMed ID: 15698721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National sentinel surveillance of antimicrobial resistance in Neisseria gonorrhoeae.
    Commun Dis Rep CDR Wkly; 2000 Jun; 10(22):195, 198. PubMed ID: 10881399
    [No Abstract]   [Full Text] [Related]  

  • 12. Neisseria meningitidis cellulitis.
    Carrascosa MF; Casuso-Sáenz E; Salcines-Caviedes JR
    Int J Infect Dis; 2012 Oct; 16(10):e760. PubMed ID: 22727693
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic susceptibility of strains isolated from patients with meningococcal disease and their household contacts in Catalonia (Spain). May 1998-April 1999.
    Cardeñosa N; Domínguez A; Carmona G; Ciruela P; Salleras L; Sánchez F; Orcau A; Follia N; Vázquez JA; Berrón S;
    Int J Antimicrob Agents; 2003 Oct; 22(4):453-5. PubMed ID: 14522110
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospects of untreatable gonorrhea and ways forward.
    Whiley DM; Lahra MM; Unemo M
    Future Microbiol; 2015; 10(3):313-6. PubMed ID: 25812453
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging fluoroquinolone resistance in Neisseria meningitidis in India: cause for concern.
    Mehta G; Goyal R
    J Antimicrob Chemother; 2007 Feb; 59(2):329-30. PubMed ID: 17185299
    [No Abstract]   [Full Text] [Related]  

  • 16. A potential role for the major iron-regulated protein expressed by pathogenic Neisseria species.
    Morse SA; Chen CY; LeFaou A; Mietzner TA
    Rev Infect Dis; 1988; 10 Suppl 2():S306-10. PubMed ID: 3142015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa.
    Moodley P; Moodley D; Willem Sturm A
    Int J Antimicrob Agents; 2004 Aug; 24(2):192-3. PubMed ID: 15288322
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gram-negative coccus infection].
    Matsumoto K; Rikitomi N; Nagatake T; Kamruddin A
    Nihon Rinsho; 1994 Feb; 52(2):367-71. PubMed ID: 8126887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neisseria meningitidis with reduced susceptibility to quinolones in Singapore.
    Donaldson AD; Tang WY; Tan AL; Barkham T
    J Antimicrob Chemother; 2010 Feb; 65(2):362-4. PubMed ID: 20007332
    [No Abstract]   [Full Text] [Related]  

  • 20. Multidrug-resistant Neisseria gonorrhoeae: future therapeutic options.
    Kahler CM
    Future Microbiol; 2018 Apr; 13():499-501. PubMed ID: 29517285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.